Forbes  Oct 14  Comment 
The Centers for Medicare & Medicaid Services released the final rule for the Medicare Access and CHIP Reauthorization Act of 2015 known as “MACRA” quality payment program that gives rural practices more flexibility and phases in requirements...
MedPage Today  Oct 13  Comment 
(MedPage Today) -- First step: inform lawmakers, public about the program
MedPage Today  Oct 11  Comment 
(MedPage Today) -- Can a new governor open the door to increased access?  Oct 10  Comment 
Data shows physicians in different disciplines vote differently. The ones who don’t take Medicaid seem to skew more Republican than those who do When Americans head to the polls in November, they’ll be deciding the fate of the Affordable Care...
Forbes  Oct 10  Comment 
Mylan will pay $465 million to settle with the Department of Justice over its classification of EpiPen in Medicaid rebate programs.
Forbes  Oct 8  Comment 
Mylan will pay $465 million to settle with the Department of Justice over its classification of EpiPen in Medicaid rebate programs.
New York Times  Oct 7  Comment 
The government said Mylan had wrongly claimed EpiPen as a generic, leading Medicare and Medicaid to overpay for it. The company said the settlement included no admission of wrongdoing.
New York Times  Oct 6  Comment 
Mylan shares slumped after reports that the company overcharged Medicaid over five years for its EpiPen allergy treatment.
Forbes  Oct 6  Comment 
Last night laboratory testing business Theranos announced that it would lay off 340 people, or 43% of its workforce, and get out of the business of administering blood tests--a business which has drawn the scrutiny of multiple government agencies...
Forbes  Oct 6  Comment 
Wellcare Health Plans? $157 million proposed acquisition of Care1st is the latest effort by national insurers to consolidate the larger Medicaid market, which has grown thanks to the Affordable Care Act.


Medicaid is the U.S. health care program for people with limited resources, and it serves low income parents, children, people with disabilities, and low income seniors. It is jointly funded by the states and the federal government and managed by the states. Medicaid is distinctly different from Medicare, which is an entitlement program funded entirely at the federal level and provides health insurance to people aged 65 and older. Medicaid is not an entitlement program, but is instead a needs-based social welfare program in which eligibility is determined by income. It covers a wider range of health services than Medicare and is funded by states as well as the federal government. It is possible to be eligible for both Medicaid and Medicare, and approximately 8.8 million Americans are enrolled in both programs.[1]

The Pharmaceutical Industry depends on Medicare and Medicaid funding for a significant percentage of its revenues. Of the two, however, Medicare's impact on the business of Health Care in America is much greater. The senior citizens of all income levels served by Medicare make up the major target population for most of the pharma industry's drugs. This is not the case for the low income, younger patients enrolled in Medicaid. Certain drugs and treatments, however, do have their revenues tied closely to Medicaid spending - notably HIV and AIDS, where more than half of people living with AIDS are estimated to receive Medicaid payments.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki